Table-II.
Group | Hb (g/L) | Hct (%) | SI (μmol/L) | ||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
T0 | T1 | T2 | T0 | T1 | T2 | T0 | T1 | T2 | |
Control group (n = 45) | 76.44±10.24 | 83.25±7.20a | 92.25±6.58ab | 24.16±4.10 | 26.44±3.95a | 29.32±3.54ab | 12.02±2.12 | 13.33±2.37a | 14.67±3.67ab |
Intervention group (n = 45) | 76.80±10.15 | 89.25±7.50a | 99.60±5.12ab | 24.40±4.13 | 30.25±3.15a | 36.25±2.54ab | 12.19±2.05 | 14.80±3.05a | 17.24±1.82ab |
t | 0.167 | 3.871 | 5.914 | 0.277 | 5.059 | 10.670 | 0.387 | 2.553 | 4.208 |
P | 0.867 | 0.000 | 0.000 | 0.783 | 0.000 | 0.000 | 0.700 | 0.012 | 0.000 |
| |||||||||
Group | TS (%) | TIBC (μmol/L) | SF (μg/L) | ||||||
| |||||||||
T0 | T1 | T2 | T0 | T1 | T2 | T0 | T1 | T2 | |
| |||||||||
Control group (n = 45) | 10.70±2.19 | 15.64±2.97a | 19.25±4.25ab | 105.26±20.15 | 89.62±12.34a | 75.62±8.01ab | 365.25±52.61 | 245.25±31.20a | 190.25±17.46ab |
Intervention group (n = 45) | 11.02±2.10 | 19.50±4.16a | 27.62±5.01ab | 106.32±20.37 | 80.62±10.07a | 67.25±6.25ab | 366.75±50.95 | 198.25±22.50a | 160.25±12.25ab |
t | 0.707 | 5.066 | 8.546 | 0.248 | 3.791 | 5.526 | 0.137 | 8.196 | 9.435 |
P | 0.481 | 0.000 | 0.000 | 0.805 | 0.000 | 0.000 | 0.891 | 0.000 | 0.000 |
Notes: Compared in the same group at T0,
p<0.05; compared in the same group at T1, bp< 0.05.